13F

Stock

TScan Therapeutics, Inc.

TCRX · held by 2 managers

Reported value

$30.7K

Holders

2

+0 new · −0 exited

Holders’ est. mark

$1.48K

Price effect on 1 books still in the name

Largest holder

$30.7K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC21.2K$30.7K$1.48KCut−$54.6K
Essential Partners LLC11$16Held

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.